vs
Side-by-side financial comparison of Ameren (AEE) and Dexcom (DXCM). Click either name above to swap in a different company.
Ameren is the larger business by last-quarter revenue ($1.8B vs $1.3B, roughly 1.4× Dexcom). Dexcom runs the higher net margin — 21.2% vs 14.2%, a 7.0% gap on every dollar of revenue. On growth, Dexcom posted the faster year-over-year revenue change (21.6% vs -8.2%). Over the past eight quarters, Dexcom's revenue compounded faster (12.0% CAGR vs -0.9%).
Ameren Corporation, together with its subsidiaries, operates as a public utility holding company in the United States. It operates through four segments: Ameren Missouri, Ameren Illinois Electric Distribution, Ameren Illinois Natural Gas, and Ameren Transmission. The company engages in the rate-regulated electric generation, transmission, and distribution activities; and rate-regulated natural gas distribution and transmission businesses. It primarily generates electricity through coal, nucle...
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.
AEE vs DXCM — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.8B | $1.3B |
| Net Profit | $253.0M | $267.3M |
| Gross Margin | — | 62.9% |
| Operating Margin | 20.2% | 25.6% |
| Net Margin | 14.2% | 21.2% |
| Revenue YoY | -8.2% | 21.6% |
| Net Profit YoY | 21.6% | 153.6% |
| EPS (diluted) | $0.92 | $0.67 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $1.3B | ||
| Q4 25 | $1.8B | $1.3B | ||
| Q3 25 | $2.7B | $1.2B | ||
| Q2 25 | $2.2B | $1.2B | ||
| Q1 25 | $2.1B | $1.0B | ||
| Q4 24 | $1.9B | $1.1B | ||
| Q3 24 | $2.2B | $994.2M | ||
| Q2 24 | $1.7B | $1.0B |
| Q1 26 | — | $267.3M | ||
| Q4 25 | $253.0M | $267.3M | ||
| Q3 25 | $641.0M | $283.8M | ||
| Q2 25 | $277.0M | $179.8M | ||
| Q1 25 | $290.0M | $105.4M | ||
| Q4 24 | $208.0M | $151.7M | ||
| Q3 24 | $457.0M | $134.6M | ||
| Q2 24 | $260.0M | $143.5M |
| Q1 26 | — | 62.9% | ||
| Q4 25 | — | 62.9% | ||
| Q3 25 | — | 60.5% | ||
| Q2 25 | — | 59.5% | ||
| Q1 25 | — | 56.9% | ||
| Q4 24 | — | 58.9% | ||
| Q3 24 | — | 59.7% | ||
| Q2 24 | — | 62.4% |
| Q1 26 | — | 25.6% | ||
| Q4 25 | 20.2% | 25.6% | ||
| Q3 25 | 30.6% | 20.1% | ||
| Q2 25 | 18.5% | 18.4% | ||
| Q1 25 | 20.5% | 12.9% | ||
| Q4 24 | 10.2% | 17.0% | ||
| Q3 24 | 27.0% | 15.3% | ||
| Q2 24 | 21.3% | 15.7% |
| Q1 26 | — | 21.2% | ||
| Q4 25 | 14.2% | 21.2% | ||
| Q3 25 | 23.7% | 23.5% | ||
| Q2 25 | 12.5% | 15.5% | ||
| Q1 25 | 13.8% | 10.2% | ||
| Q4 24 | 10.7% | 13.6% | ||
| Q3 24 | 21.0% | 13.5% | ||
| Q2 24 | 15.4% | 14.3% |
| Q1 26 | — | $0.67 | ||
| Q4 25 | $0.92 | $0.67 | ||
| Q3 25 | $2.35 | $0.70 | ||
| Q2 25 | $1.01 | $0.45 | ||
| Q1 25 | $1.07 | $0.27 | ||
| Q4 24 | $0.77 | $0.37 | ||
| Q3 24 | $1.70 | $0.34 | ||
| Q2 24 | $0.97 | $0.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $13.0M | $917.7M |
| Total DebtLower is stronger | $19.4B | — |
| Stockholders' EquityBook value | $13.4B | $2.7B |
| Total Assets | $48.5B | $6.3B |
| Debt / EquityLower = less leverage | 1.45× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $917.7M | ||
| Q4 25 | $13.0M | $917.7M | ||
| Q3 25 | $9.0M | $1.8B | ||
| Q2 25 | $11.0M | $1.2B | ||
| Q1 25 | $23.0M | $904.9M | ||
| Q4 24 | $7.0M | $606.1M | ||
| Q3 24 | $17.0M | $621.2M | ||
| Q2 24 | $19.0M | $939.2M |
| Q1 26 | — | — | ||
| Q4 25 | $19.4B | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $17.8B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | $2.7B | ||
| Q4 25 | $13.4B | $2.7B | ||
| Q3 25 | $12.8B | $2.7B | ||
| Q2 25 | $12.3B | $2.6B | ||
| Q1 25 | $12.2B | $2.3B | ||
| Q4 24 | $12.1B | $2.1B | ||
| Q3 24 | $11.8B | $2.0B | ||
| Q2 24 | $11.5B | $2.4B |
| Q1 26 | — | $6.3B | ||
| Q4 25 | $48.5B | $6.3B | ||
| Q3 25 | $47.4B | $7.5B | ||
| Q2 25 | $46.6B | $7.3B | ||
| Q1 25 | $45.7B | $6.8B | ||
| Q4 24 | $44.6B | $6.5B | ||
| Q3 24 | $43.3B | $6.4B | ||
| Q2 24 | $42.3B | $6.8B |
| Q1 26 | — | — | ||
| Q4 25 | 1.45× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.47× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $956.0M | — |
| Free Cash FlowOCF − Capex | $-54.0M | — |
| FCF MarginFCF / Revenue | -3.0% | — |
| Capex IntensityCapex / Revenue | 56.7% | — |
| Cash ConversionOCF / Net Profit | 3.78× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-775.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $956.0M | $294.0M | ||
| Q3 25 | $1.1B | $659.9M | ||
| Q2 25 | $862.0M | $303.0M | ||
| Q1 25 | $431.0M | $183.8M | ||
| Q4 24 | $817.0M | $301.4M | ||
| Q3 24 | $897.0M | $199.5M | ||
| Q2 24 | $557.0M | $279.4M |
| Q1 26 | — | — | ||
| Q4 25 | $-54.0M | $192.1M | ||
| Q3 25 | $116.0M | $579.4M | ||
| Q2 25 | $-204.0M | $208.9M | ||
| Q1 25 | $-633.0M | $96.8M | ||
| Q4 24 | $-473.0M | $176.8M | ||
| Q3 24 | $-240.0M | $88.3M | ||
| Q2 24 | $-445.0M | $213.3M |
| Q1 26 | — | — | ||
| Q4 25 | -3.0% | 15.3% | ||
| Q3 25 | 4.3% | 47.9% | ||
| Q2 25 | -9.2% | 18.1% | ||
| Q1 25 | -30.2% | 9.3% | ||
| Q4 24 | -24.4% | 15.9% | ||
| Q3 24 | -11.0% | 8.9% | ||
| Q2 24 | -26.3% | 21.2% |
| Q1 26 | — | — | ||
| Q4 25 | 56.7% | 8.1% | ||
| Q3 25 | 36.6% | 6.7% | ||
| Q2 25 | 48.0% | 8.1% | ||
| Q1 25 | 50.7% | 8.4% | ||
| Q4 24 | 66.5% | 11.2% | ||
| Q3 24 | 52.3% | 11.2% | ||
| Q2 24 | 59.2% | 6.6% |
| Q1 26 | — | — | ||
| Q4 25 | 3.78× | 1.10× | ||
| Q3 25 | 1.72× | 2.33× | ||
| Q2 25 | 3.11× | 1.69× | ||
| Q1 25 | 1.49× | 1.74× | ||
| Q4 24 | 3.93× | 1.99× | ||
| Q3 24 | 1.96× | 1.48× | ||
| Q2 24 | 2.14× | 1.95× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
